Biopharmaceuticals: The Patent System and Incentives for Innovation

DSpace/Manakin Repository

Biopharmaceuticals: The Patent System and Incentives for Innovation

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Lipton, Alissa K. en_US
dc.date.accessioned 2012-06-07T20:07:21Z
dc.date.issued 2004 en_US
dc.identifier.citation Biopharmaceuticals: The Patent System and Incentives for Innovation (2004 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852103
dc.description.abstract This paper discusses the requirements for patentability as applied to biotechnology and pharmaceutical inventions. Focusing on case law from the Court of Appeals for the Federal Circuit, as well as guidelines issued by the United States Patent and Trademark Office, the Paper describes the requirements of utility, novelty, nonobviousness, written description, and enablement. The Paper then goes on to summarize literature on the economics of patents and the structure of the biotechnology industry. The Paper argues that strong patent protection is vital in order to ensure innovation in the biotechnology industry. Finally, the Paper addresses issues in patenting recent developments in biotechnology. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject patentability en
dc.title Biopharmaceuticals: The Patent System and Incentives for Innovation en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-06-07T20:07:21Z

Files in this item

Files Size Format View
Lipton.pdf 284.0Kb PDF View/Open
Lipton.rtf 254.9Kb RTF file View/Open
Lipton.html 209.2Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters